All About Multiple Sclerosis

More MS news articles for January 2004

A two-stage study on multiple sclerosis susceptibility and chromosome 2q33

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14724692&dopt=Abstract

Genes Immun. 2004 Jan 15
Bonetti A, Reunanen K, Finnila S, Koivisto K, Wikstrom J, Sumelahti ML, Pirttila T, Elovaara I, Reunanen M, Saarela J, Peltonen L, Rantamaki T, Tienari PJ.
Neuroscience Programme, Department of Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki University Central Hospital, Haartmaninkatu 4, Helsinki, Finland.

We have performed a two-stage study to analyse the association of polymorphism on chromosome 2q33 with multiple sclerosis (MS).

In all, 17 markers were analysed in stage-1 in 134 Finnish MS families and the observed associations were tested in stage-2 in 186 MS families.

We did not find previously reported allelic or haplotype associations with CTLA4.

We obtained a weak signal of two distinct predisposing genes, one proximal the other distal of CTLA4.

The putative proximal gene was associated with the marker rs3977 in families lacking HLA-DR2 (P=0.02 and 0.02) and the other distal gene was associated with D2S1271 in families from a high-risk region in western Finland (P=0.02 and 0.01).

Based on the >3 cM distance and the lack of linkage disequilibrium between these loci, we conclude that the two association signals are independent.

Our results provide preliminary evidence for two distinct MS susceptibility genes on 2q33 outside of CTLA4.